Magnetic resonance imaging contrast agent related pulmonary edema: a case report

Gadobutrol is a contrast agent often used during magnetic resonance imaging (MRI). The agent has several side effects, some of which can be serious. It has extremely rare life-threatening systemic complications, which can lead to bronchospasm, hypersensitivity reactions and cardiovascular arrest. Ho...

Full description

Saved in:
Bibliographic Details
Published inEuropean review for medical and pharmacological sciences Vol. 16 Suppl 4; p. 110
Main Authors Demirhan, A, Yasar Tekelioglu, U, Akkaya, A, Dagistan, E, Suzi Ayhan, S, Ozturk, S, Yildiz, I, Kocoglu, H
Format Journal Article
LanguageEnglish
Published Italy 01.10.2012
Subjects
Adult
Contrast Media - adverse effects
Humans
Magnetic Resonance Imaging - adverse effects
Male
Organometallic Compounds - adverse effects
Pulmonary Edema - chemically induced
Online AccessGet more information

Cover

More Information
Summary:Gadobutrol is a contrast agent often used during magnetic resonance imaging (MRI). The agent has several side effects, some of which can be serious. It has extremely rare life-threatening systemic complications, which can lead to bronchospasm, hypersensitivity reactions and cardiovascular arrest. However, there is no data available on the development of noncardiogenic pulmonary edema following use of gadobutrol. This paper examines the case of a 37-year-old male patient reported to have developed noncardiogenic pulmonary edema after intravenous injection of gadobutrol during MRI.
ISSN:1128-3602